Rapid Buprenorphine Induction Cuts Overdoses in Shelter Study

Starting medication-assisted treatment may not have to wait for days of detox and stabilization. A new case series found that a single rapid injection of extended-release buprenorphine, given within 24 hours of intake to people actively using fentanyl, was followed by a steep drop in monthly overdoses and no serious adverse events.

Skipping the Sublingual Step

Standard clinical pathways usually require patients to stabilize on sublingual buprenorphine, taken as a tablet or film under the tongue, before receiving the extended-release injectable form.

That requirement can stall or stop treatment for people in unstable housing, where daily dosing is hard to manage. The reviewed protocol removed that step entirely.

Researchers examined all 21 people who received at least one off-label injection through a virtual opioid dependency program partnered with two harm reduction sites offering supervised consumption services, shelter-based housing, or both.

Every participant met diagnostic criteria for opioid use disorder, faced a high clinical risk of recurrent overdose, had prior buprenorphine exposure without allergy, and had no history of substance-induced seizures.

All 21 were actively using illicit fentanyl at intake, and seven reported fentanyl use within four hours of their injection. Participants received 300 milligrams of extended-release buprenorphine within 24 hours of intake.

Overdoses Fell Sharply After Treatment

Monthly opioid overdose incidence dropped from a mean of 0.87 overdoses per month before treatment to 0.08 after, a difference the authors measured with a Wilcoxon signed-rank test (Z = -3.54, p = 0.0004).

Retention told a similar story. Of the participants, 57 percent received at least one maintenance dose, and 75 percent of those who returned did so within 42 days.

The authors describe the approach as safe and associated with significant overdose reductions, while cautioning that a small retrospective case series cannot prove the protocol works. Larger prospective studies remain necessary to confirm the findings.

Understanding Extended-Release Buprenorphine

Buprenorphine is a medication used to treat opioid use disorder. As a partial opioid agonist, it activates the brain’s opioid receptors enough to ease withdrawal and cravings without producing the full effects of drugs like fentanyl or heroin.

The extended-release version is given as an injection that releases the medication steadily for a month at a time.

Because it is long-acting, patients do not have to manage daily doses, a practical advantage for people living in shelters or without stable housing.

In this study, the injections were used off-label, meaning prescribers went beyond the medication’s approved instructions by skipping the usual sublingual start.

Medication-Assisted Treatment Without the Wait

Rapid induction does not replace medical detox. It changes how quickly people can move from withdrawal into stable medication-assisted treatment.

Opioid withdrawal is rarely life-threatening, but it is miserable enough to push many people back to fentanyl within hours, which is why medically managed withdrawal gives patients a real chance to continue care.

Alcohol and benzodiazepine withdrawal are different, because both can be fatal without supervision. For fentanyl users, the study’s deeper lesson is that low-barrier programs, including shelter-based care, can deliver safe treatment to people the traditional system loses.

Finding Medical Detox in the United States

The research took place in Canada, but its audience includes every American community where fentanyl dominates the drug supply. Shelters, harm reduction programs, and street medicine teams across the United States serve the same population this protocol reached.

If you or a loved one is dependent on fentanyl or other opioids, ask any detox program whether it offers buprenorphine in both sublingual and extended-release forms, and whether induction can begin quickly.

The Detox.com directory can help you compare medical detox and medication-assisted treatment providers and find a program that starts care without delay.